Factors associated with adherence to post-treatment follow-up among a cohort of women with acetic acid/Lugol's iodine positive lesions of the cervix in Cameroon: A retrospective cohort study
- PMID: 37727369
- PMCID: PMC10505974
- DOI: 10.1016/j.gore.2023.101269
Factors associated with adherence to post-treatment follow-up among a cohort of women with acetic acid/Lugol's iodine positive lesions of the cervix in Cameroon: A retrospective cohort study
Abstract
Background: Women treated for cervical precancerous lesions have up to a 30 % increased risk of developing cervical cancer compared to women in the general population. The aim of this study was to identify predictors for adherence to follow-up among women treated for precancerous lesions of the cervix in Cameroon.
Materials and methods: The study design was a retrospective cohort analysis of a five-year follow-up for women in Cameroon who were initially treated for cervical precancer lesions in 2013. Logistic regression models were used to determine factors associated with adherence to post-treatment follow-up. Statistical significance was set at p < 0.05.
Results: Of the 344 women treated in 2013, 154 (44.77 %) never returned for a single post-treatment follow-up in five years. Marital status was the only variable statistically significantly associated with 5-year post-treatment follow-up adherence. women who had ever been married were 0.36 times (0.14 0.93)); p = 0. 0.035] less likely to adhere to post-treatment follow-up compared to women who have never been married. Although age was not statistically significant, women in the age group 30-49 years had some significance and they were 60 % [aOR, 95 %CI: 0.40 (0.18 0.89); p = 0.024] less likely to adhere to post-treatment follow-up when compared to women who were<30 years.
Conclusion: Only about half of the women treated for cervical precancer in this cohort returned for post-treatment follow-up. Conducting needs assessments among these populations that are less likely to adhere to follow-up will allow us to implement and test strategies to improve adherence to follow-up.
Keywords: Acetic acid/Lugol’s solution; Cameroon; Follow-up study; HIV seropositivity; Precancerous conditions; Uterine cervical neoplasms.
© 2023 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Impact of telephone reminders on posttreatment follow-up among women treated for cervical precancers in Cameroon: A randomized controlled trial.Gynecol Oncol Rep. 2025 Apr 19;59:101745. doi: 10.1016/j.gore.2025.101745. eCollection 2025 Jun. Gynecol Oncol Rep. 2025. PMID: 40309313 Free PMC article.
-
Factors Associated with Treatment Uptake Among Women with Acetic Acid/Lugol's Iodine Positive Lesions of the Cervix in Cameroon.Int J Womens Health. 2020 Jun 25;12:495-504. doi: 10.2147/IJWH.S249607. eCollection 2020. Int J Womens Health. 2020. PMID: 32612397 Free PMC article.
-
Cervical digital photography for screening of uterine cervix cancer and its precursor lesions in developing countries.Arch Gynecol Obstet. 2013 Jul;288(1):183-9. doi: 10.1007/s00404-013-2745-8. Epub 2013 Feb 12. Arch Gynecol Obstet. 2013. PMID: 23400355
-
Prevention of cervical cancer in HIV-seropositive women from developing countries through cervical cancer screening: a systematic review.Syst Rev. 2018 Nov 17;7(1):198. doi: 10.1186/s13643-018-0874-7. Syst Rev. 2018. PMID: 30447695 Free PMC article.
-
Accuracy of combinations of visual inspection using acetic acid or lugol iodine to detect cervical precancer: a meta-analysis.BJOG. 2018 Apr;125(5):545-553. doi: 10.1111/1471-0528.14783. Epub 2017 Jul 26. BJOG. 2018. PMID: 28603909
Cited by
-
Cervical Precancer Treatment Outcomes in Cameroon.Int J MCH AIDS. 2024 Sep 13;13:e020. doi: 10.25259/IJMA_8_2024. eCollection 2024. Int J MCH AIDS. 2024. PMID: 39526171 Free PMC article.
-
Impact of telephone reminders on posttreatment follow-up among women treated for cervical precancers in Cameroon: A randomized controlled trial.Gynecol Oncol Rep. 2025 Apr 19;59:101745. doi: 10.1016/j.gore.2025.101745. eCollection 2025 Jun. Gynecol Oncol Rep. 2025. PMID: 40309313 Free PMC article.
-
Comparing a "See-and-Treat" HPV-Based to VIA-Based Cervical Cancer Prevention Strategies Among Women Living with HIV in Cameroon: A Pilot Study.Res Sq [Preprint]. 2025 Jul 28:rs.3.rs-7097928. doi: 10.21203/rs.3.rs-7097928/v1. Res Sq. 2025. PMID: 40766226 Free PMC article. Preprint.
References
-
- Aerssens A., Claeys P., Garcia A., Sturtewagen Y., Velasquez R., Vanden Broeck D., Vansteelandt S., Temmerman M., Cuvelier C.A. Natural history and clearance of HPV after treatment of precancerous cervical lesions. Histopathology. 2008;52(3):381–386. - PubMed
-
- Bae J.H., Kim C.J., Park T.C., Namkoong S.E., Park J.S. Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure. BMC Public Health. 2007;17(6):1271–1277. - PubMed
-
- Cox, J.T., Chelmow, D.P., & Moscicki, A.B. (2014). Management of Abnormal Cervical Cancer Screening. In: Mayeaux, E.J., & Cox, J.T. (Eds.), Modern Colposcopy: Textbook and Atlas, 3rd ed., Philadelphia PA, pp. 571–598.
LinkOut - more resources
Full Text Sources